Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-01-16 @ 1:20 AM
Study NCT ID:
NCT04517357
Status:
COMPLETED
Last Update Posted:
2025-02-24
First Post:
2020-08-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients
Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Relapsed Ovarian Cancer | View |
Keywords: